Health technology firm started by Dallas native lands $175 million investment to expand

Austin-based health technology company Everlywell has raised $175 million to expand its digital health offerings and its workforce.

Everlywell was founded by Dallas native Julia Cheek in 2015, and the company moved to Austin in 2016.

Everlywell focuses on home health care diagnostics, including at-home tests for food sensitivity, allergies, thyroid issues, hormones and vitamins. The company also has received authorization for an at-home test kit for COVID-19.

New investors in the financing round include funds and accounts managed by BlackRock, the Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures and Portfolia, as well as existing investors Goodwater Capital, Highland Capital Partners and Next Coast Ventures.

This investment brings the total capital raised by the company to more than $250 million.

“The pandemic has shed light on the challenges of lab testing for Americans, from unknown costs to confusion and inconvenience,” Cheek said. “We’ve been empowering people with

Read More

UofL Health first in Kentucky to use new ‘Monarch’ technology for detecting lung cancer

Thousands of people die every year from lung cancer and Kentucky is at the top of the list for the number of people with the disease.



Monarch technology


© Provided by WLKY Louisville
Monarch technology

Now, doctors are hoping new technology at UoL Health Jewish Hospital will help change those statistics and save lives. The new technology is called the Monarch.


Sign up for our Newsletters

“So the Monarch is a robotic navigational bronchoscopy,” said Dr. Matthew Black, UofL Health Jewish Hospital.

Black describes it as a lighted camera allowing surgeons to see a patient’s airway and lungs. UofL Health Jewish Hospital is the first in Kentucky to use it to help detect lung cancer earlier.

Black, a thoracic surgeon, performed the first procedure in November.

“This technology allows us to get further into the peripheral lung which is where most lung cancers start and by utilizing this technology we can

Read More

Health tech venture firm OTV closes new $170 million fund and expands into Asia

OTV (formerly known as Olive Tree Ventures), an Israeli venture capital firm that focuses on digital health tech, announced it has closed a new fund totaling $170 million. The firm also launched a new office in Shanghai, China to spearhead its growth in the Asia Pacific region.

Loading...

Load Error

OTV currently has a total of 11 companies in its portfolio. This year, it led rounds in telehealth platforms TytoCare and Lemonaid Health, and its other investments include genomic machine learning platform Emedgene; microscopy imaging startup Scopio; and at-home cardiac and pulmonary monitor Donisi Health. OTV has begun investing in more B and C rounds, with the goal of helping companies that already have validated products deal with regulations and other issues as they grow.

OTV focuses on digital health products that have the potential to work in different countries, make healthcare more affordable, and fill gaps in overwhelmed healthcare systems.

Read More

WSU launches health science incubator to build, grow startups in Spokane

Washington State University has launched a new incubator to grow early-stage health care and life science startup companies.

Spinout Space in Spokane – also known as sp3nw – will offer startups assistance with grant preparation; operational and intellectual property support; and legal and marketing services in the Ignite Northwest building at 120 N. Pine St., according to a news release.

It also will provide startups with a offices, lab space and an opportunity to interact with WSU faculty, a mentor network of established entrepreneurs and nearly three dozen consultants, investor groups and service providers. 

The network of consultants and mentors will aid in the process of commercializing health care products, while driving economic and job growth in the region, according to the news release.

The Bank of America Charitable Foundation awarded sp3nw with a $250,000 grant that will go toward attracting and retaining biotech, pharmaceutical, diagnostics and medical device companies,

Read More

Health and health care of individuals with autism — ScienceDaily

People on the autism spectrum face barriers to comprehensive care that may cause their health and quality of life to be worse than that of their peers. While some people may be predisposed to worse health, preventive services and comprehensive health care can go a long way in improving the trajectory of health throughout their lives.

In the recently published sixth report in the National Autism Indicators Report series, researchers from Drexel University’s A.J. Drexel Autism Institute highlight a holistic picture of what health and health care look like across the life course for people on the autism spectrum.

“Health and health care are critical issues for many children and adults on the autism spectrum,” said Lindsay Shea, DrPH, director of the Policy and Analytics Center at the Autism Institute and interim leader of the Life Course Outcomes Research Program, an associate professor and co-author of the report. “They may

Read More

Obama, Bush, Clinton Would Take Coronavirus Vaccine on Camera to Show Safety | Health News

Former Presidents Barack Obama, George W. Bush and Bill Clinton have all said they are willing to take the new coronavirus vaccine when available, possibly even doing so on TV to show that the vaccine is safe.

Obama said on an episode of SiriusXM’s “The Joe Madison Show” airing Thursday that he will take a COVID-19 vaccine whenever it becomes available to him.

“I promise you that when it’s been made for people who are less at risk, I will be taking it,” Obama said in audio that was released on YouTube. “I may end up taking it on TV or having it filmed, just so that people know that I trust this science. What I don’t trust is getting COVID.”

Cartoons on the Coronavirus

Bush’s chief of staff on Wednesday confirmed to CNN that the former president reached out to Dr. Anthony Fauci, director of the National Institute of

Read More

Global data challenge winners investigating county-level COVID-19 impact of in-person college classes; social determinants of health

( NewMediaWire ) – December 03, 2020 – DALLAS – Researchers from University of Michigan and University of Alabama studying the impact of in-person college classes on community COVID-19 cases and the affect social determinants of health play in virus outbreaks and deaths won the top awards in the American Heart Association’s first ever COVID-19 data challenge. The challenge focused on understanding the relationships between COVID-19 and other risk factors, health conditions, health disparities and social determinants of health that may bring a higher burden of illness or mortality.

After rigorous peer review by a panel of 26 U.S.-based data science and public health experts, these teams have been selected as winners:

  • Grand Prize ($15,000): Brahmajee Nallamothu, M.D., and Ji Zhu, Ph.D., University of Michigan, in Ann Arbor, led the project “Population-based Features and Their Association with Coronavirus Disease 2019 Infection in the United States.” The team analyzed national data
Read More

Microsoft: Here’s how your smartphone camera plus AI can keep an eye on your health

While wearables are at the forefront of medical applications for mobile technology, COVID-19 has sent researchers looking at older technologies like the humble smartphone for remote diagnosis. 

Microsoft Research has been working on telehealth applications via a smartphone for over a decade, but the current pandemic presents new opportunities that make the approach more relevant than it was even a year ago. 

Telehealth has held promise in healthcare since the advent of video but smartphones, better cameras and artificial intelligence might produce a more workable an answer at time when it’s difficult for people to visit medical facilities due to the pandemic. 

As the Center for Disease Control and Prevention (CDC) noted in June, telehealth can help provide patients with care while minimizing the risk patients passing on of SARS-CoV-2 — the virus that causes COVID-19 — to doctors and nurses.

Microsoft points out that atrial fibrillation (AFib) is a

Read More

Study examines role of mobile health technology in monitoring COVID-19 patients

Study examines role of mobile health technology in monitoring Covid-19 patients
Wearable devices are viable options to monitor Covid-19 patients and predict symptom escalation for earlier intervention. Credit: Tammy Ko

A 60-person task force, including MIT Lincoln Laboratory researchers, has published a study reviewing mobile health (mHealth) technologies and examining their use in monitoring and mitigating the effects of the COVID-19 pandemic. They found that mHealth technologies are viable options to monitor COVID-19 patients and predict symptom escalation for earlier intervention.

The study, “Can mHealth Technology Help Mitigate the Effects of the COVID 19 Pandemic?”, is published in the IEEE Open Journal of Engineering in Medicine and Biology. The task force was led by Harvard Medical School Associate Professor Paolo Bonato, director of the Motion Analysis Lab at Spaulding Rehabilitation Hospital in Boston, and included international experts and those from across the United States.

The study reviewed mHealth technologies in three categories—wearable sensors, digital contact tracing technology, and electronic patient-recorded

Read More

Pfizer coronavirus vaccine approved for emergency use in UK: ‘Help is on the way’ | Health care/Hospitals

British officials authorized a COVID-19 vaccine for emergency use on Wednesday, greenlighting the world’s first shot against the virus that’s backed by rigorous science and taking a major step toward eventually ending the pandemic.

The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany’s BioNTech comes as the coronavirus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

The Medicines and Healthcare Products Regulatory Agency, which licenses drugs in the U.K., recommended the vaccine could be used after it reviewed the results of clinical trials that showed the vaccine was 95% effective overall — and that it also offered significant protection for older people, among those most at risk of dying from the disease. But the vaccine remains experimental while final testing is done.

“Help is on its way,” British

Read More